Leerink Partners Reiterates Outperform Rating on IDEXX Laboratories (IDXX)

June 26, 2025 8:01 AM EDT Send to a Friend
Leerink Partners analyst Daniel Clark reiterated an Outperform rating and $580.00 price target on IDEXX Laboratories (NASDAQ: IDXX).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login